Delivery Order 75N91019D00029-75N91019F00129
Award Date
8/31/19
Potential Completion Date
8/30/24
Potential Value
$20M
Federal Agency
National Cancer Institute
Awardee
The Broad Institute, Inc.
Ultimate Awardee
Not listed
PSC Category
B529 - Special Studies/Analysis- Scientific Data
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Cambridge, MA 02142, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
5
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the National Cancer Institute (NCI) to The Broad Institute, Inc., doing business as Broad Institute of MIT and Harvard. The contract is part of the NCI Genomic Characterization Centers indefinite delivery, indefinite quantity (IDIQ) vehicle, with a ceiling value of $3,890,489.86 and a completion date of September 9, 2026. The contract is for firm fixed-price services related to NCI's Genomic Characterization Center program, which supports advanced...
This federal contract award, valued at $166,819,979.48, was issued by the National Cancer Institute (NCI) to The Broad Institute, Inc. (doing business as Broad Institute of MIT and Harvard), a non-profit biomedical and genomic research organization. The contract is for the Sequencing for the Cancer Genome Atlas (TCGA) Program, which supports the generation and analysis of genomic data to advance cancer research. The Broad Institute will provide a range of scientific services, including genomic...
This is a delivery order contract awarded by the National Cancer Institute (NCI) to The Broad Institute, Inc. for DNA whole genome sequencing (WGS) services in support of new CCG (Chronic Condition Genomics) studies. The contract has a period of performance from September 1, 2020 to August 31, 2023, with a total ceiling value of $2,677,314.06. This delivery order is part of the larger NCI Genomic Characterization Centers contract vehicle, which provides advanced genomic research and sequencing...
This federal contract award to The Broad Institute, Inc., doing business as Broad Institute of MIT and Harvard, is valued at $1,285.00 and has no set-aside designation. The contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID) for "OTHER FUNCTIONS SEQUENCING SERVICE." The Broad Institute is a non-profit biomedical and genomic research organization that partners with universities, medical centers, and companies to advance the understanding of human...
This is a delivery order under a multi-year, multi-award Indefinite Delivery Contract (IDC) awarded by the National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to the Broad Institute of MIT and Harvard. The $24,910,368.70 firm fixed-price task order is for the Broad Institute to provide genomics data generation, analysis, and management services in support of the NHLBI's Trans-Omics for Precision Medicine (TOPMed) initiative. This work will...
This firm fixed-price purchase order for $108,629.18 was awarded by the National Institute of Environmental Health Sciences, a civilian agency, to The Broad Institute, Inc. for whole exome sequencing services. The contract has no set-aside designation, reflecting The Broad Institute's competitive capabilities in advanced genomic research and data analysis services. The Broad Institute has performed similar work for other federal agencies like the Centers for Disease Control and Prevention,...
This is a firm fixed-price purchase order awarded by the National Institute on Aging (NIA), a civilian agency, to The Broad Institute, Inc. doing business as Broad Institute of MIT and Harvard, a non-profit biomedical and genomic research organization. The $241,554.00 contract is for procode-based strategies for large-scale imaging of induced pluripotent stem cells (iPSCs) and iPSC-derived cell types. The Broad Institute has received numerous prime and subcontract awards from agencies like the...
This federal contract award was issued by the National Heart, Lung and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), to The Broad Institute, Inc., doing business as Broad Institute of MIT and Harvard. The $2,343,147.64 firm fixed price contract is a delivery order under the Centralized Omic REsource for TOPMed (CORE) indefinite delivery vehicle (IDV), which has a $500 million ceiling to support the Trans-Omics for Precision Medicine initiative through genomics data...
This is a federal contract award valued at $394,227.01 to The Broad Institute, Inc., doing business as Broad Institute of MIT and Harvard, a non-profit biomedical and genomic research organization. The contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), for TAS::75 0885::TAS BIOMEDICAL (APPLIED/EXPLORATORY) services. The contract has no set-aside designation. The Broad Institute frequently partners...
This is a $37,876,167 Firm Fixed Price definitive contract awarded by the National Heart Lung and Blood Institute (NHLBI) to The Broad Institute, Inc., a non-profit research organization. The contract supports the Trans-Omics for Precision Medicine (TOPMed) initiative through genomics data generation, analysis, and management services. This is an indefinite delivery contract with a 10-year, $500 million ceiling. The Broad Institute was also awarded a multiple-award Indefinite Delivery Indefinite...